Published in Blood on May 15, 2002
Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica (2009) 1.65
Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med (2009) 1.41
von Willebrand factor: an emerging target in stroke therapy. Stroke (2011) 1.34
Platelet adhesion under flow. Microcirculation (2009) 1.31
Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex. Proc Natl Acad Sci U S A (2012) 1.01
Newer agents in antiplatelet therapy: a review. J Blood Med (2012) 0.94
Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals. Lasers Med Sci (2007) 0.93
Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study. PLoS One (2014) 0.82
On the versatility of von Willebrand factor. Mediterr J Hematol Infect Dis (2013) 0.78
Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor. Mol Ther (2011) 0.77
A modified Folts model or the original Folts model to evaluate new antithrombotics? Blood (2003) 0.75
Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina. Br J Pharmacol (2013) 0.75
Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med (2007) 2.37
Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid (2004) 2.28
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Circulation (2014) 2.16
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood (2010) 1.75
Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report. Arterioscler Thromb Vasc Biol (2010) 1.74
Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell (2006) 1.67
Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood (2009) 1.65
Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood (2008) 1.45
Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. Thromb Haemost (2006) 1.43
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica (2008) 1.41
Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem (2005) 1.34
Platelets at work in primary hemostasis. Blood Rev (2011) 1.34
Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood (2003) 1.18
Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood (2010) 1.16
Unwinding the von Willebrand factor strings puzzle. Blood (2012) 1.13
von Willebrand factor to the rescue. Blood (2009) 1.13
Thyroid-stimulating monoclonal antibodies. Thyroid (2002) 1.07
Platelet adhesion to collagen. Thromb Res (2011) 1.04
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. Arterioscler Thromb Vasc Biol (2008) 1.02
Laboratory diagnosis and molecular classification of von Willebrand disease. Acta Haematol (2009) 1.01
Role of glycoprotein Ibalpha in phagocytosis of platelets by macrophages. Transfusion (2006) 1.01
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br J Haematol (2007) 1.01
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites. J Biol Chem (2004) 1.00
Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood (2010) 1.00
Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor. Blood (2006) 0.99
Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol (2005) 0.99
Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4. Thromb Haemost (2006) 0.98
Antiplatelet drugs. Br J Haematol (2008) 0.98
Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol (2004) 0.97
Inherited traits affecting platelet function. Blood Rev (2008) 0.97
Model systems of genetically modified platelets. Blood (2011) 0.96
Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood (2006) 0.95
Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thromb Haemost (2013) 0.91
Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood (2004) 0.91
Characterization of the thyrotropin binding pocket. Thyroid (2002) 0.90
Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. J Biol Chem (2005) 0.89
Blood platelet biochemistry. Thromb Res (2011) 0.89
The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Thromb Haemost (2008) 0.89
Von Willebrand factor: drug and drug target. Cardiovasc Hematol Disord Drug Targets (2009) 0.89
Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. Blood (2002) 0.87
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost (2007) 0.87
Inhibition of platelet glycoprotein Ib and its antithrombotic potential. Curr Pharm Des (2007) 0.87
Shear-stress-induced conformational changes of von Willebrand factor in a water-glycerol mixture observed with single molecule microscopy. J Phys Chem B (2014) 0.87
New insights into von Willebrand disease and platelet function. Semin Thromb Hemost (2012) 0.86
Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts. Haematologica (2012) 0.86
Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons. Arterioscler Thromb Vasc Biol (2002) 0.86
A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction. J Biol Chem (2003) 0.86
Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and Fc RIIa in immune thrombocytopenia. Haematologica (2013) 0.85
New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp Hematol (2004) 0.85
Platelet physiology and antiplatelet agents. Clin Chem Lab Med (2010) 0.85
Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis. J Biol Chem (2011) 0.84
Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain. Proteins (2004) 0.84
von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol (2003) 0.83
A common ancestral glycoprotein (GP) 9 1828A>G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier Syndrome (BSS). Thromb Haemost (2005) 0.83
The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation. J Biol Chem (2009) 0.82
Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha. J Biol Chem (2007) 0.82
Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain. J Biol Chem (2005) 0.81
The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha. Thromb Haemost (2007) 0.81
Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF. Blood (2007) 0.80
Testosterone and acute stress are associated with fibrinogen and von Willebrand factor in African men: the SABPA study. Int J Cardiol (2013) 0.80
Platelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein Ibα. Haematologica (2013) 0.80
Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma. Haematologica (2007) 0.79